[What have we learned from converting enzyme inhibitors on renin-angiotensin system?]

Details

Serval ID
serval:BIB_8D7CB8995636
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
[What have we learned from converting enzyme inhibitors on renin-angiotensin system?]
Journal
Revue du Praticien
Author(s)
Waeber  B., Nussberger  J., Brunner  H. R.
ISSN
0035-2640 (Print)
Publication state
Published
Issued date
12/1992
Volume
42
Number
20
Pages
2529-32
Notes
English Abstract
Journal Article
Review --- Old month value: Dec 15
Abstract
Angiotensin-converting-enzyme (ACE) inhibitors are now widely used to treat patients with high blood pressure or heart failure. The favourable results obtained with these inhibitors of the renin-angiotensin system suggest that angiotensin II has a noxious effect on the development and/or course of these diseases. ACE inhibitors are usually well tolerated. Their most severe side-effects are mostly foreseeable and therefore avoidable. Chronic blockade of the renin-angiotensin system increasingly seems to be a good therapeutic approach to the protection of the vital organs.
Keywords
Angiotensin-Converting Enzyme Inhibitors/adverse effects/*pharmacology Humans Peptidyl-Dipeptidase A/*physiology Renin-Angiotensin System/*drug effects/physiology
Pubmed
Create date
05/03/2008 16:40
Last modification date
20/08/2019 14:51
Usage data